Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: ABEONA THERAPEUTICS

Complaint inspection · Health discipline

On , OSHA opened a complaint health inspection of ABEONA THERAPEUTICS in 6555 CARNEGIE AVE, CLEVELAND, OH 44103 (NAICS 325412). OSHA activity number 345927628.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Abeona Therapeutics — free Get an email when a new federal OSHA severe-injury report for Abeona Therapeutics is published. One employer, no account, unsubscribe in one click.
Establishment
ABEONA THERAPEUTICS
Site address
6555 CARNEGIE AVE
City
CLEVELAND
State
OH
ZIP
44103
Mailing
6555 CARNEGIE AVE, CLEVELAND, OH 44103
Inspection type
Complaint (B)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
Employees
59
Ownership type
A

8 citations on file for this inspection.

1910.132 A

Serious Gravity 5 1 instance 10 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $7,252 · Current $7,252
29 CFR  1910.132(a): Protective equipment, including personal protective equipment for eyes, face, head, and extremities, protective clothing, respiratory devices, and protective shields and barriers, were not provided, used, and maintained in a sanitary and reliable condition wherever it is necessary by reason of hazards of processes or environment, chemical hazards, radiological hazards, or mechanical irritants encountered in a manner capable of causing injury or impairment in the function of any part of the body through absorption, inhalation or physical contact.   On or about April 29, 2022 the employer did not provide protective clothing such as a moisture impervious laboratory coat to protect employees against physical contact and absorption during the manufacturing of a custom retrovirus.
Recent events (2)
  • — I (S) $7252
  • — Z (S) $7252

1910.132 D02

Serious Gravity 5 1 instance 10 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $0 · Current $0
29 CFR  1910.132(d)(2): The employer did not verify, through a written certification, that the required workplace hazard assessment had been performed.   On or about April 29, 2022 the employer did not verify, through written certification,  that the required workplace hazard assesment had been performed in the manufacturing area of the facility.
Recent events (2)
  • — I (S) $0
  • — Z (S) $0

1910.151 C

Serious Gravity 5 1 instance 10 exposed
Issued
Aug 9, 2022
Abate by
Dec 30, 2022
Penalty
Initial $5,801 · Current $5,801
29 CFR  1910.151(c): Where employees were exposed to injurious corrosive materials, suitable facilities for quick drenching or flushing of the eyes and body were not provided within the work area for immediate emergency use.  On or about April 29, 2022 the employer did not provide suitable facilities for quick drenching or flushing of the eyes and body where employees were exposed to injurious corrosive materials such as, but not limited to, 10% bleach and Spor-Klenz used to clean up biohazardous spills in the manufacturing area.
Recent events (2)
  • — I (S) $5801
  • — Z (S) $5801

1910.1030 C01 I

Other-than-serious Gravity 10 1 instance 59 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $10,151 · Current $3,000 Reduced
29 CFR  1910.1030(c)(1)(i): The employer having employee(s) with occupational exposure did not establish a written Exposure Control Plan designed to eliminate or minimize employee exposure.  On or about April 29, 2022 the employer did not establish a written Exposure Control Plan for employees exposed to bloodborne pathogens while handling biohazardous material including, but not limited to; blood, skin, and live viruses.
Recent events (2)
  • — I (O) $3000
  • — Z (S) $10151

1910.1030 F02 I

Other-than-serious Gravity 10 1 instance 59 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $0 · Current $0
29 CFR  1910.1030(f)(2)(i): Hepatitis B vaccination was not made available after the employee had received the training required in 29 CFR 1910.1030(g)(2)(vii)(I) or within 10 working days of initial assignment to employees who had occupational exposure. Vaccination is not required for those employees who had previously received the complete hepatitis B vaccination series; antibody testing has revealed that the employee is immune; or the vaccine.  On or about April 29, 2022 the employer did not make the Hepatitis B vaccination available for employees with occupational exposure to blood or other potentially infectious materials while handling biohazardous material including, but not limited to; blood, skin, and live viruses.
Recent events (2)
  • — I (O) $0
  • — Z (S) $0

1910.1450 E01

Other-than-serious Gravity 5 1 instance 59 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $7,252 · Current $2,000 Reduced
29 CFR  1910.1450(e)(1): Where hazardous chemicals were used in the workplace, the employer did not develop and carry out the provisions of a written Chemical Hygiene Plan which was capable of protecting employees from health hazards associated with hazardous chemicals:  On or about April 29, 2022 the employer did not have a written Chemical Hygiene Plan in place to protect employees engaged in the small-scale manufacturing of products inside of the laboratory from health hazards associated with hazardous chemicals such as, but not limited to custom viruses, Bleach, and SporKlenz.
Recent events (2)
  • — I (O) $2000
  • — Z (S) $7252

1910.1450 F01

Other-than-serious Gravity 5 1 instance 59 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $0 · Current $0
29 CFR  1910.1450(f)(1): The employer did not provide laboratory employees with information and training to ensure that they were apprised of the hazards of chemicals present in their work area.  On or about April 29, 2022 the employer did not provide laboratory employees with information and training on the hazards of chemicals in the workplace to include but not limited to custom viruses, Bleach, and SporzKlenz while engaged in small-scale production activity.
Recent events (2)
  • — I (O) $0
  • — Z (S) $0

1910.1030 G02 VII N

Other-than-serious 1 instance 59 exposed
Issued
Aug 9, 2022
Abate by
Sep 2, 2022
Penalty
Initial $0 · Current $0
29 CFR  1910.1030(g)(2)(vii)(N): The bloodborne pathogens training program did not contain an opportunity for interactive questions or answers with the person conducting the training session.  On or about April 29, 2022 the employer's bloodborne pathogens training program did not contain an opportunity for interactive questions or answers during the bloodborne pathogens training in that it was conducted online.
Recent events (2)
  • — I (O) $0
  • — Z (O) $0

View Abeona Therapeutics's full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 345927628.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.